Hydrofarm Holdings Group, Inc. — FY2021 Form 10-K
Reporting period: Year ended December 31, 2021; this is an annual report, not a separate fourth-quarter report. Hydrofarm manufactures and distributes controlled-environment agriculture (CEA) equipment and supplies, principally in the U.S. and Canada, mainly through wholesale and retail customers. Figures below are in U.S. dollars.
Key financial results
| Metric | FY2021 | FY2020 |
|---|---|---|
| Net sales | $479.4 million | $342.2 million |
| Gross profit / gross margin | $101.5 million / 21.2% | $63.6 million / 18.6% |
| Operating income (loss) / margin | $(2.7) million / (0.6)% | $4.3 million / 1.3% |
| Net income (loss) | $13.4 million | $(7.3) million |
| Adjusted EBITDA / margin | $47.1 million / 9.8% | $21.1 million / 6.2% |
| Net cash used in operating activities | $(45.1) million | $(44.8) million |
| Cash, cash equivalents and restricted cash at year-end | $28.4 million | $77.0 million |
Sales increased 40.1%: management attributed the increase to 35.0% higher volume (13.1% organic and 21.9% from recently acquired brands), 3.6% price and mix, and 1.5% favorable foreign exchange. The gross-margin improvement reflected a higher mix of proprietary and preferred-brand products, partly offset by rising freight and labor costs, particularly in the second half.
Net income included a $19.1 million income-tax benefit, principally from releasing valuation allowance following acquisition-related deferred tax accounting. The company reported a $5.7 million pretax loss. Adjusted EBITDA is a non-GAAP measure; FY2021 included $24.2 million of acquisition and integration expenses, among other adjustments.
Financial position, liquidity and debt
- At December 31, 2021, current assets were $269.4 million and current liabilities were $88.4 million. Inventory was $189.1 million, up from $88.6 million a year earlier.
- Operating cash outflow was $45.1 million, with a reported $62.9 million increase in working capital cited as a principal use of cash. Investing cash outflow was $468.2 million, including $462.2 million net cash paid for acquisitions. Financing provided $464.7 million.
- Long-term debt was $119.5 million, plus $2.3 million current debt; reported total debt was $121.8 million, including finance lease obligations and other debt. The $125 million senior secured term loan matures in October 2028 and has variable-rate pricing. Scheduled quarterly principal payments begin March 2022.
- The $100 million JPMorgan revolving facility had no balance outstanding at year-end; approximately $83.6 million was available to borrow. The company reported compliance with its debt covenants, including the revolver’s 1.1x minimum fixed-charge coverage ratio. Substantially all relevant assets secure the facilities.
Material changes and notable items
- Hydrofarm completed five acquisitions in 2021: Heavy 16, House & Garden, Aurora, Greenstar/Grotek and Innovative Growers Equipment. The acquisitions expanded proprietary nutrient, growing-media and equipment brands and manufacturing capabilities. Purchase accounting remained preliminary for certain acquisitions; the auditor identified acquisition intangible-asset valuation as a critical audit matter.
- The company raised approximately $309.8 million net in a May follow-on offering and received $56.8 million gross from warrant exercises. Shares outstanding rose to 44.6 million at year-end from 33.5 million a year earlier.
- Gross margin improved, but SG&A rose to $103.9 million from $58.5 million, reflecting acquisition and integration costs, compensation, insurance, marketing and other public-company and growth expenses.
- Operating cash flow remained materially negative as sales growth required substantial working capital. Management said cash flows and available credit were expected to meet capital expenditure, working-capital and debt needs for the foreseeable future, while cautioning that future cash generation and borrowing availability were not assured.
Outlook, risks and contingencies
The filing provides no specific revenue, earnings or cash-flow guidance. Management expected acquisition activity to proceed at a slower pace, particularly in the first half of 2022, as it integrated the 2021 acquisitions, while continuing to evaluate opportunities. Management cited long-term CEA market growth potential but noted that cannabis oversupply had recently pressured growing activity.
- Supply-chain disruption, extended lead times, freight, labor and raw-material inflation could constrain product availability or margins; management reported elevated shipping costs and lead times, though no material order-fulfillment interruption to date.
- Demand is indirectly exposed to cannabis-market conditions and rapidly changing state and federal laws. Credit-facility terms restrict direct sales to specified cannabis customers, potentially limiting market access.
- Acquisition integration, manufacturing execution, purchase-price estimates, goodwill and intangible-asset valuation, and contingent consideration create execution and accounting risks. Contingent consideration included $17.0 million in current liabilities at year-end, largely related to Aurora.
- On January 31, 2022, certain unintegrated Aurora-related computer systems were subject to a cybersecurity attack. The company reported no evidence at that time that the incident extended to its main systems or financial-reporting controls; investigation and remediation were ongoing, and costs could not yet be estimated.
- Management and the auditor concluded internal control over financial reporting was effective as of year-end, and prior material weaknesses were reported remediated. The assessment excluded the five 2021 acquisitions, which represented 85% of net assets, 68% of total assets, 13% of revenue and 37% of net income in the consolidated amounts.
- The company reported no legal proceeding or claim expected to have a material adverse effect, while noting ordinary-course claims. It also disclosed that it does not maintain product-liability insurance. No dividends are anticipated in the foreseeable future.
Important facts for investors to verify
- Whether organic demand and the reported price/mix gains can offset any moderation in CEA or cannabis-related activity.
- How acquisition integration, final purchase-price allocations, acquired-brand performance and contingent payments affect reported earnings and cash generation.
- Whether inventory and receivables growth converts to operating cash flow, and whether available revolver capacity and covenant headroom remain adequate.
- The effect of variable interest rates, scheduled term-loan amortization and secured-debt covenants on future interest expense and financial flexibility.
- The final scope, costs and any data impact of the Aurora-related cyber incident, and the extension of effective financial controls to acquired businesses.